In MYCN-amplified NB cells, after inhibiting the expression of PTK2 with two PTK2 small-molecule inhibitors, the proliferation of tumor cells was significantly reduced, the percentage of cells in the G1 phase was significantly increased, and that in the S phase was decreased [80]. The gene discussed is MYCN; the disease is neoplasm.